Carson Advisory Inc. Invests $246,000 in Grail, Inc. (NASDAQ:GRAL)

Carson Advisory Inc. bought a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 13,800 shares of the company's stock, valued at approximately $246,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. FNY Investment Advisers LLC purchased a new stake in Grail in the fourth quarter worth $26,000. Lindbrook Capital LLC bought a new stake in Grail during the fourth quarter worth about $28,000. Sterling Capital Management LLC purchased a new stake in Grail in the fourth quarter worth about $29,000. Wellington Shields Capital Management LLC bought a new position in Grail during the 4th quarter valued at approximately $33,000. Finally, New York State Common Retirement Fund purchased a new position in Grail in the fourth quarter worth about $59,000.

Analyst Ratings Changes

Separately, Morgan Stanley lifted their price objective on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th.

Insider Buying and Selling

In related news, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $56,659.20. Following the sale, the chief financial officer now owns 335,170 shares of the company's stock, valued at approximately $10,457,304. This trade represents a 0.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, President Joshua J. Ofman sold 2,109 shares of the business's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the sale, the president now owns 559,673 shares in the company, valued at approximately $17,461,797.60. The trade was a 0.38 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 11,550 shares of company stock valued at $360,436.

Grail Stock Performance

NASDAQ GRAL traded up $0.50 during trading hours on Friday, hitting $27.00. 642,745 shares of the company's stock traded hands, compared to its average volume of 1,221,381. The business's fifty day moving average price is $32.95 and its two-hundred day moving average price is $23.48. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last released its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analysts' expectations of $35.33 million. On average, research analysts anticipate that Grail, Inc. will post -15.15 earnings per share for the current year.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.